Synaptic Vesicle Cycle Hijacking: Shared Convergent Mechanism for α-Synuclein (PD) and Tau (AD) Trans-synaptic Propagation
🧪 Overview
Convergence hypothesis: Both α-synuclein (SNCA) in Parkinson's disease and tau (MAPT) in Alzheimer's disease exploit the same synaptic vesicle cycle machinery for trans-synaptic propagation, making the vesicle trafficking pathway a shared therapeutic target.
PD-specific mechanism: α-synuclein binds to synaptic vesicles (SYP, SV2A, SYNPR) at the presynaptic terminal, inducing conformational conversion of endogenous α-synuclein into β-sheet-rich oligomers. These oligomers traffic in both directions across the synapse via activity-dependent exo/endocytosis, explaining the stereotypical pattern of Lewy body spreading (Braak stages I-VI).
AD-specific mechanism: Tau enters synapses via a distinct but overlapping mechanism: GSK3B-phosphorylated tau (pThr231, pSer396) binds to synaptic vesicle glycoprotein SYF2 and CPEB3, undergoing activity-dependent release in exosomes (SDPR, RSPH3). The tau seed competent strain propagates trans-synaptically and drives downstream amyloidogenic processing (APP, BACE1) in the receiving neuron.
🧬 Mechanism
Curated pathway from expert analysis
flowchart TD
A["Presynaptic Vesicle Cycle<br/>SNAP25 VAMP2 DNM1"]
B["SNCA Vesicle Binding<br/>Conformational Conversion"]
C["MAPT Tau Seed Uptake<br/>Endocytic Synaptic Entry"]
D["CAV1 and Endosome Sorting<br/>Shared Trafficking Hub"]
E["Exocytosis and Reuptake Loop<br/>Trans Synaptic Transfer"]
F["PD and AD Propagation Convergence<br/>SNCA Tau Spread"]
G["Vesicle Cycle Intervention<br/>Shared Therapeutic Target"]
A --> B
A --> C
B --> D
C --> D
D --> E
E --> F
G -.->|"targets"| A
style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style F fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a⚖️ Evidence
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — SNCA
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for SNCA,MAPT,SNAP25,DNM1,VAMP2,CAV1.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
📊 Market Indicators
💾 Resource Usage
No resource usage or linked notebooks recorded for this hypothesis yet.
🔮 Predictions
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| Human post-mortem tissue from PD (Braak III-IV) and AD (Braak V-VI) both show increased DNM1 and decreased VAMP2 at the synapse compared to controls. | — | — no observation — | open | 0.73 |
| SNAP25 knockdown in A53T SNCA;MAPT P301S double-transgenic mice will reduce both phospho-Ser129 α-synuclein AND phospho-Ser396 tau in the hippocampus by >50%. | — | — no observation — | open | 0.70 |
▸Metadatasource: v1_phase_c_backfill · origin_type: comparative_synthesis
| source | v1_phase_c_backfill |
| origin_type | comparative_synthesis |
| _schema_version | 1 |